Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.63−0.34 (-1.31%)
Close on Nov 18, 2026Market cap $983.63MP/E –Yield –
Ceribell shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Ceribell's shares outstanding was 38M at Jun 30, 2026. For fiscal 2025 it was 37M, up 205.8% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37M | +205.8% |
| FY2024 | Dec 31, 2024 | 12M | +125.3% |
| FY2023 | Dec 31, 2023 | 5M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 38M | +4.8% |
| Q1 FY2026 | Mar 31, 2026 | 38M | +5.0% |
| Q4 FY2025 | Dec 31, 2025 | 37M | +560.0% |
| Q3 FY2025 | Sep 30, 2025 | 37M | +562.0% |
| Q2 FY2025 | Jun 30, 2025 | 36M | +565.0% |
| Q1 FY2025 | Mar 31, 2025 | 36M | +565.4% |
| Q3 FY2024 | Sep 30, 2024 | 6M | +5.5% |
| Q2 FY2024 | Jun 30, 2024 | 6M | – |
| Q1 FY2024 | Mar 31, 2024 | 5M | – |
| Q4 FY2023 | Dec 31, 2023 | 5M | – |
| Q3 FY2023 | Sep 30, 2023 | 5M | – |
See a number that looks wrong?